Drawing based on the description in the official product monograph. No photo yet.
“12.5 mg capsules: Yellow to orange colored granular powder filled in Size '4' hard gelatin capsules with orange opaque cap and orange opaque body, printed with white ink "NATCO" on cap and "12.5 mg" on body”
NATCO 12.5 mg pill
Pill with imprint NATCO 12.5 mg is orange & yellow, capsule and has been identified as Sunitinib Malate 12.5 mg. It is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors. It is supplied by Natco Pharma (Canada) Inc.
Sold in Canada
Sunitinib Malate 12.5 mg
- Brand
- Nat-Sunitinib
- Imprint
- NATCO 12.5 mg
- Strength
- 12.5 mg
- Used for
- Renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors
- Color
- Orange, Yellow
- Shape
- Capsule / oblong
- Form
- Capsule
- Manufacturer
- Natco Pharma (Canada) Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02552892
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Sunitinib Malate used for?
Sunitinib Malate is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Gastrointestinal Stromal Tumor
Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
Advanced Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC).
Adjuvant Treatment of Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.
Advanced Pancreatic Neuroendocrine Tumors
Sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows NATCO 12.5 mg. The parts can be split between the two sides, so turn the pill over and check both.
- It is orange & yellow, capsule.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Nat-Sunitinib by Natco Pharma (Canada) Inc.
In Canada: prescription only.
Ingredients
Active: Sunitinib (Sunitinib Malate)
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
IPX203 350
Carbidopa and Levodopa 87.5 mg / 350 mg
Orange & white, capsule, 23 mm
Used for Parkinson's disease
-
G 369
Topiramate 100 mg
Gray & orange, capsule, 19 mm
Used for bipolar disorder and focal seizures
-
G 368
Topiramate 50 mg
Gray & orange, capsule, 16 mm
Used for bipolar disorder and focal seizures
-
SD TC 5 mg
Tacrolimus 5 mg
Orange, capsule, 21 mm
Used for eczema
-
SD TC 1 mg
Tacrolimus 1 mg
Orange & yellow, capsule, 14 mm
Used for eczema
-
SD TC 0 5 mg
Tacrolimus 0.5 mg
Orange & pink, capsule, 11 mm
Used for eczema
Other Sunitinib Malate pills
- SC 12 5 Sunitinib Malate 12.5 mg Gray, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- MYLAN SM 12 5 Sunitinib Malate 12.5 mg Pink, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- STN 12 5 Sunitinib Malate 12.5 mg Yellow, capsule, 11 mm Used for renal cell carcinoma and pancreatic neoplasms
- RM53 RM53 Sunitinib Malate 12.5 mg Brown, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- S12 5 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- 6 MS Sunitinib Malate 12.5 mg Orange, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- TEVA 8199 TEVA 8199 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- Pfizer STN 12 5 mg Sunitinib Malate 12.5 mg Orange, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms